In FY15, every incremental rupee of money supply generated just Rs 1.2 of incremental gross domestic product
Sources say Alkem Laboratories' Rs 1,350-crore IPO and Dr Lal PathLabs' Rs 633-crore IPO will open from December 7 to 9
Share of IT, pharma, and FMCG companies in Sensex to rise to 38% next month; manufacturing losing sheen
Banks and finance firms accounted for 31% of BSE 500 companies' profits in 2014-15 versus their 20.6% profit share in S&P 500
Core operating margins in July-Sept quarter down 165 basis points, sequentially
Net sales growth decline 4.4% in September quarter, the second worst in eight years; net profit grows at the fastest pace in four quarters
Promoters' holding in private sector BSE 500 companies declined to 43.4% in Sept
Developed countries see double-digit growth, emerging ones witness contraction
Thanks to the recent rally, now the index is more expensive than it was at 2014-end or when it hit a life-time high in January
Lower IT exports will raise India's dependence on capital flows to fund imports
Poor global demand might make it tough for India to crank its growth engine
Net profit up 3.9% in July-September quarter, net sales decline 9.5%
Titan's flagship brand fights to maintain its premium positioning even as feisty traditional players beat it at its own game
Combined net sales and net profit estimated to drop 4.5% and 2.3%, respectively, on a Y-o-Y basis
For top IT services firms, revenue growth in FY15 was the slowest since the Lehman crisis
Market cap of top-4 metal producers at 11-yr low on China woes; price-earnings lowest since early 1990s
For over-leveraged companies such as GMR Infra, Adani Power, Tata Power, IRB Infra and Tata Steel, cash flow mismatch and poor profitability are bigger issues than cost of funds
For Nifty companies, actual earnings have fallen short of analyst estimates in every year since the Lehman crisis of 2008
There are more companies listed and traded on the BSE than in eight other major emerging markets combined